| Male | Female | All |
---|---|---|---|
Number of patients | 57 | 43 | 100 |
Age at exam (in years) | 54.0 ± 13.9 (20–83) | 54.2 ± 15.7 (19–84) | 54.1 ± 14.7 (19–84) |
AEDs | Â | Â | Â |
 NA | 26 | 27 | 53 |
 L | 19 | 11 | 30 |
 SA | 4 | 1 | 5 |
 NK | 5 | 3 | 8 |
 UA | 3 | 1 | 4 |
Motor deficit | Â | Â | Â |
 ND | 41 | 31 | 72 |
 D | 16 | 12 | 28 |
Tumor location | Â | Â | Â |
 RO | 19 | 16 | 35 |
 FR | 15 | 9 | 24 |
 PA | 11 | 8 | 19 |
 PoG | 11 | 6 | 17 |
 TE | 1 | 4 | 5 |
Tumor side | Â | Â | Â |
 LH | 23 | 17 | 40 |
 RH | 34 | 26 | 60 |
Dominancy | Â | Â | Â |
 NDO | 28 | 25 | 53 |
 DO | 26 | 16 | 42 |
Edema | Â | Â | Â |
 NE | 37 | 31 | 68 |
 E | 20 | 12 | 32 |
Tumor entity | Â | Â | Â |
 II | 8 | 6 | 14 |
 III | 4 | 6 | 10 |
 IV | 21 | 17 | 38 |
 ME | 14 | 11 | 25 |
 X | 10 | 3 | 13 |
Tumor recurrence | Â | Â | Â |
 NR | 44 | 34 | 78 |
 R | 13 | 9 | 22 |
Tumor volume (in cm3) | 27.2 ± 5.4 (19.9–42.9) | 26.1 ± 5.0 (20.3–39.9) | 26.7 ± 5.2 (19.9–42.9) |
rMT (in %) | 31.9 ± 7.5 (20–59) | 36.4 ± 10.6 (22–72) | 33.8 ± 9.3 (20–72) |
Year of mapping | Â | Â | Â |
 Y10 | 13 | 16 | 29 |
 Y11 | 14 | 6 | 20 |
 Y12 | 10 | 5 | 15 |
 Y13 | 20 | 16 | 36 |